ProQR Therapeutics NV appointed David Rodman as chief development strategy officer.
Rodman has served as a chief medical officer at miRagen Therapeutics Inc. and Nivalis Therapeutics Inc.
ProQR Therapeutics appoints chief development strategy officer
Identifying PPE Suppliers During the Pandemic
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021
Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective
ProQR Therapeutics appoints chief development strategy officer
- Author Imran Khushal
- Theme Healthcare & Pharmaceuticals
- Author
- Imran Khushal
- Theme
- Healthcare & Pharmaceuticals